Search Results - "Garrido, Marlene"
-
1
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Published in The Journal of clinical investigation (01-03-2019)“…The cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway detects cytosolic DNA to activate innate immune responses. Poly(ADP-ribose) polymerase…”
Get full text
Journal Article -
2
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer
Published in Cancer research (Chicago, Ill.) (01-06-2021)“…Inactivation of ( ), a specific subunit of the PBAF chromatin remodeling complex, occurs frequently in cancer, including 40% of clear cell renal cell…”
Get full text
Journal Article -
3
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus–Induced Cryoglobulinemia Vasculitis
Published in Gastroenterology (New York, N.Y. 1943) (01-06-2017)“…Background & Aims Interferon-free direct-acting antiviral (DAA) therapies are effective in patients with hepatitis C virus–induced cryoglobulinemia vasculitis…”
Get full text
Journal Article -
4
Immunomodulatory role of Interleukin-33 in large vessel vasculitis
Published in Scientific reports (14-04-2020)“…The mechanisms regulating inflammation in large vessels vasculitis (LVV) are poorly understood. Interleukin 33 (IL-33) has been shown to license innate and…”
Get full text
Journal Article -
5
Interleukin 21 Correlates with T Cell and B Cell Subset Alterations in Systemic Lupus Erythematosus
Published in Journal of rheumatology (01-09-2012)“…Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by alterations of the B cell subset, global regulatory T cell (Treg) depletion, and…”
Get full text
Journal Article -
6
Large-vessel vasculitis in human immunodeficiency virus-infected patients
Published in Journal of vascular surgery (01-05-2018)“…The objective of this study was to describe large-vessel vasculitis (LVV) in patients with human immunodeficiency virus (HIV) infection. It is a retrospective…”
Get full text
Journal Article -
7
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
Published in The Journal of clinical investigation (02-04-2018)“…Synthetic lethality is an efficient mechanism-based approach to selectively target DNA repair defects. Excision repair cross-complementation group 1 (ERCC1)…”
Get full text
Journal Article -
8
Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs
Published in Cell reports. Medicine (18-06-2024)“…Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive sarcoma driven by the EWSR1::WT1 chimeric transcription factor. Despite this unique oncogenic…”
Get full text
Journal Article -
9
Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity
Published in The Journal of immunology (1950) (15-12-2011)“…Homeostasis of peripheral B cell subsets is disturbed during chronic hepatitis C virus (HCV) infection, leading to the occurrence of autoimmunity and B cell…”
Get full text
Journal Article -
10
Behçet's disease physiopathology: a contemporary review
Published in Autoimmunity highlights (01-12-2016)“…Behçet's disease, also known as the Silk Road Disease, is a rare systemic vasculitis disorder of unknown etiology. Recurrent attacks of acute inflammation…”
Get full text
Journal Article -
11
mTOR Pathway Activation in Takayasu Arteriti
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-10-2017)Get full text
Journal Article -
12
Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high‐risk patients
Published in British journal of haematology (01-07-2014)“…Summary Although purine analogues have significantly improved the outcome of hairy cell leukaemia (HCL) patients, 30–40% relapse, illustrating the need for…”
Get full text
Journal Article -
13
DNA repair deficiency sensitizes lung cancer cells to [NAD.sup.+] biosynthesis blockade
Published in The Journal of clinical investigation (01-04-2018)“…Synthetic lethality is an efficient mechanism-based approach to selectively target DNA repair defects. Excision repair cross-complementation group 1 (ERCC1)…”
Get full text
Journal Article -
14
Immunomodulatory role of Interleukin-33 in large vessel vasculitis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-10-2017)Get full text
Journal Article -
15
Abstract 6277: Identification of ATR inhibitors as therapeutic opportunities in Desmoplastic small round cell tumors
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Introduction: Desmoplastic small round cell tumor (DSRCT) is a rare and very aggressive subtype of sarcoma, affecting predominantly young males. DSRCT…”
Get full text
Journal Article -
16
Post-Induction Minimal Residual Disease (MRD) Defines a Large Subset of Adults with Favorable Ph-Negative Acute Lymphoblastic Leukemia (ALL), Who Do Not Benefit From Allogeneic Stem Cell Transplantation (SCT) in First Complete Remission: A GRAALL Study
Published in Blood (20-11-2009)“…Abstract 577▪▪This icon denotes an abstract that is clinically relevant. Allogeneic SCT is currently the preferred therapeutic option for most younger adults…”
Get full text
Journal Article -
17
Replication Stress is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors
Published in Cancer research (Chicago, Ill.) (16-10-2024)“…Desmoplastic small round cell tumor (DSRCT) is an aggressive sarcoma subtype that is driven by the EWS-WT1 chimeric transcription factor. The prognosis for…”
Get full text
Journal Article -
18
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer
Published in Cancer research (Chicago, Ill.) (01-06-2021)“…Abstract Inactivation of Polybromo 1 (PBRM1), a specific subunit of the PBAF chromatin remodeling complex, occurs frequently in cancer, including 40% of clear…”
Get full text
Journal Article -
19
Abstract 1058: Targeting chromatin remodeling-associated genetic vulnerabilities in cancer: PBRM1 defects are synthetic lethal with PARP and ATR inhibitors
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Aim: Polybromo-1 (PBRM1), a specific subunit of the pBAF chromatin remodeling complex, is frequently inactivated in cancer. For example, 40% of clear…”
Get full text
Journal Article -
20
Immunomodulatory role of Interleukin-33 in large vessel vasculitis
Published in Scientific reports (01-12-2020)“…The mechanisms regulating inflammation in large vessels vasculitis (LVV) are poorly understood. Interleukin 33 (IL-33) has been shown to license innate and…”
Get full text
Journal Article